For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Overview of Global Luliconazole market:
According to our latest research, the global Luliconazole market looks promising in the next 5 years. As of 2022, the global Luliconazole market was estimated at USD 196.43 million, and it's anticipated to reach USD 288.08 million in 2028, with a CAGR of 6.59% during the forecast years.
Luliconazole is a novel topical antifungal imidazole with broad-spectrum and potent antifungal activity. Luliconazole is a novel, optically active antifungal imidazole. The compound has a unique chemical structure which is augmented by the introduction of an imidazole moiety into the ketene dithioacetate structure. By this modification, an unusually high potency against filamentous fungi, including dermatophytes, was achieved while maintaining the broad antifungal spectrum of an imidazole. Luliconazole is used to treat skin infections such as athlete's foot, jock itch, and ringworm. Luliconazole is an azole antifungal that works by preventing the growth of the fungus.
Short-term negative growth
During COVID-19, in order to prevent and control the epidemic, major economies adopted home isolation and production suspension policies. This will affect the production efficiency of the manufacturing industry in the short term, the production cycle on the supply side will become longer, and the supply of the industrial chain will also be hindered, thereby increasing production costs. In the short term, business operations are facing challenges that will adversely affect the development of the industry.
In the long run, demand will pick up steadily
Fungus patients rely more on highly effective antifungal treatment products. With the post-epidemic era, the recovery of productivity, the gradual stabilization of product supply chains, and the promotion of vaccines, market confidence has recovered. The supply of fungal treatment products has gradually returned to normal, and the production of Luliconazole has gradually stabilized. With the recovery of logistics and digital transformation, product supply will gradually stabilize. In the long run, with the increase in the incidence of fungi, people's needs are still increasing.
Strengths
Increase in demand
Azoles are widely used to treat superficial and invasive fungal infections. The drug has fewer side effects, less severe drug interactions, and enhanced absorption and distribution characteristics. In the current market, the prevalence of fungal infections is increasing due to an aging population and an increase in patients with compromised immune systems. Although most infections caused by fungi are non-fatal in nature, they can cause great inconvenience to people who suffer from it and require appropriate medications to cure them. The market size of dermatophytosis in 2018 was US$2.79 billion. Due to the increasing prevalence of skin infections, especially children's skin infections, the demand for Luliconazole drugs has increased.
Weaknesses
Limitations of existing effects
Luliconazole is a new type of topical imidazole antifungal drug used to treat skin infections. It has low solubility and poor skin permeability, which limits its therapeutic application. Luliconazole has the shortcomings of low skin retention, low water solubility, and poor skin permeability, and other carrier methods are needed to expand the overall application effect.
Region Overview:
In global comparison, a significant portion of the revenue was generated in United States (37.29% in 2021).
Company Overview:
Bausch Health Companies Inc is one of the major players operating in the Luliconazole market, holding a share of 36.41% in 2022.
Bausch Health Companies Inc
Bausch Health Companies Inc. is a multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology.
NIHON NOHYAKU CO., LTD.
Nihon Nohyaku Co. Ltd. produces and markets a variety of insecticides and fungicides. The Company also works in pharmaceuticals, veterinary drugs, and other chemical-related fields.
Segmentation Overview:
As for product types, the Strength (10g:100 mg) segment held the largest market share in 2021.
Strength (5g:50 mg)
The total amount of the drug is 5g, of which the total content of Luliconazole is 50mg, and the content of Luliconazole in the drug is 1%. It is used for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum.
Strength (10g:100 mg)
The total amount of the drug is 10g, of which the total content of Luliconazole is 100mg, and the content of Luliconazole in the drug is 1%. It is used for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum.
Application Overview:
The market's largest segment by application is the segment Interdigital Tinea Pedis, with a market share of 46.95% in 2021.
Interdigital Tinea Pedis
Interdigital tinea pedis (often referred to as athlete's foot) is the most common form and is predominantly caused by T. rubrum. It is characterized by macerated skin with fissures between the toes (usually between the fourth and fifth toes) and frequently erythema. Patients with interdigital tinea pedis can be treated with topical antifungal drugs, such as Luliconazole.
Tinea Cruris
Tinea cruris is a specific form of tinea due to a dermatophyte fungus affecting the groin, pubic region, and adjacent thigh. Luliconazole is used to treat tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks) skin infections that cause red scaly rashes on different parts of the body.
Tinea Corporis
Tinea corporis is a superficial fungal skin infection of the body caused by dermatophytes. Luliconazole is used for the topical treatment of tinea corporis caused by the organism.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Luliconazole market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.
Key Takeaways from the Global Luliconazole Market Report:
Market Size Estimates: Luliconazole market size estimation in terms of value and sales volume from 2018-2028
Market Trends and Dynamics: Luliconazole market drivers, opportunities, challenges, and risks
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Luliconazole market
Segment Market Analysis: Luliconazole market value and sales volume by type and by application from 2018-2028
Regional Market Analysis: Luliconazole market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa
Country-level Studies on the Luliconazole Market: Revenue and sales volume of major countries in each region
Luliconazole Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.
Trade Flow: Import and export volume of the Luliconazole market in major regions.
Luliconazole Industry Value Chain: Luliconazole market raw materials & suppliers, manufacturing process, distributors, downstream customers
Luliconazole Industry News, Policies & Regulations
Key players in the global Luliconazole market are covered in Chapter 12:
Zydus
Emcure Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
NIHON NOHYAKU CO.,LTD.
Bausch Health Companies Inc
Hainan Hailing
brinton pharmaceuticals ltd
In Chapter 2 and Chapter 15.1, based on types, the Luliconazole market from 2018 to 2028 is primarily split into:
Strength (5g:50 mg)
Strength (10g:100 mg)
In Chapter 3 and Chapter 15.2, based on applications, the Luliconazole market from 2018 to 2028 covers:
Interdigital Tinea Pedis
Tinea Cruris
Tinea Corporis
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:
North America (Covered in Chapter 7)
United States
Canada
Asia-Pacific (Covered in Chapter 8)
China
Japan
India
South Korea
Southeast Asia
Australia
Others
Europe (Covered in Chapter 9)
Germany
France
UK
Italy
Spain
Russia
Poland
Others
Latin America (Covered in Chapter 10)
Mexico
Brazil
Argentina
Others
Middle East and Africa (Covered in Chapter 11)
GCC Countries
Africa
Others
The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.
In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.
Chapter Outline
This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 starts the report with an overview of the Luliconazole market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.
Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.
Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.
Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.
Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.
Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.
Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.
Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.
Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.
Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.
Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028